Document is current
Any future updates will be listed below
-
Authors
Li, Linqing https://orcid.org/0000-0003-3003-9902
Yang, Jinling
Perry, Luba
Bays, Jennifer L. https://orcid.org/0000-0003-0218-2680
Bhatia, Sangeeta N.
Eyckmans, Jeroen
Chen, Christopher S. https://orcid.org/0000-0003-2445-8449
- License Information
-
More Information
Article History
Received: 3 May 2025
Accepted: 24 September 2025
First Online: 14 November 2025
Competing interests
: C.S.C. is a founder and own shares of Satellite Biosciences and RopirioTherapeutics. S.N.B. holds equity in Amplifyer Bio, Catalio Capital, Earli, Impilo Therapeutics, Matrisome Bio, Ochre Bio, Port Therapeutics, RopirioTherapeutics, Satellite Bio, Sunbird Bio, and Vertex Pharmaceuticals, advises Danaher, Moderna, Pictet, and Xilio Therapeutics, and receives sponsored research funding from Johnson & Johnson, and Owlstone Medical. The remaining authors declare no competing interests. The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
